Linnet Biopharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in Redding, CA and active since 2010.
Linnet Biopharmaceuticals Inc was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Stan Linnet at the company’s single location by writing to 3060 Crossroads Drive, Redding, California CA 96002 or by phoning (315) 287-0141. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Linnet Biopharmaceuticals Inc |
| Contact Person: | Stan Linnet |
| Address: | 3060 Crossroads Drive, Redding, California 96002 |
| Phone Number: | (315) 287-0141 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Linnet Biopharmaceuticals Inc was started in 2010 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Stan Linnet for inquiries that concern Linnet Biopharmaceuticals Inc by calling the company number (315) 287-0141, as your correspondence is most welcome. Additionally, the physical location of the single location of Linnet Biopharmaceuticals Inc can be found at the coordinates 40.562562,-122.29832 as well as the street address 3060 Crossroads Drive in Redding, California 96002.
For its online presence, you may visit Linnet Biopharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.